FT576 in Subjects With Multiple Myeloma
Clinical trial NCT05182073 · COMPLETED
Trial details
- NCT number
- NCT05182073
- Sponsor
- Fate Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2024-09-20
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.